dr. A.J. van der Wekken

pulmonary oncologist

No picture available
E-mail:
a.j.van.der.wekken umcg.nl

Research

Publications
  1. Tepotinib in Non–Small-Cell Lung Cancer with MET Exon 14 Skipping Mutations

    Paik, P. K., Felip, E., Veillon, R., Sakai, H., Cortot, A. B., Garassino, M. C., Mazieres, J., Viteri, S., Senellart, H., Van Meerbeeck, J., Raskin, J., Reinmuth, N., Conte, P., Kowalski, D., Cho, B. C., Patel, J. D., Horn, L., Griesinger, F., Han, J-Y., Kim, Y-C., Chang, G-C., Tsai, C-L., Yang, J. C-H., Chen, Y-M., Smit, E. F., van der Wekken, A. J., Kato, T., Juraeva, D., Stroh, C., Bruns, R., Straub, J., Johne, A., Scheele, J., Heymach, J. V. & Le, X., 29-May-2020, In : New England Journal of Medicine. 13 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  2. Best first-line therapy for patients with advanced non-small cell lung cancer, performance status 2 without a targetable mutation or with an unknown mutation status

    Gijtenbeek, R. G. P., de Jong, K., Venmans, B. J. W., van Vollenhoven, F. H. M., Brinke, A. T., Van der Wekken, A. J. & van Geffen, W. H., 12-Aug-2019, In : Cochrane Database of Systematic Reviews. 2019, 8, 14 p., CD013382.

    Research output: Contribution to journalArticleAcademicpeer-review

View all (45) »

Press / Media
  1. Plasma testing

    Anthonie Wekken, van der

    15/11/2019

    1 Media contribution

    Press/Media: Expert CommentAcademic

  2. Longkanker in Perspectief

    Anthonie Wekken, van der

    05/11/2019

    1 Media contribution

    Press/Media: Expert CommentProfessional

  3. Oncologie longkanker special

    Anthonie Wekken, van der

    15/05/2019

    1 Media contribution

    Press/Media: Expert CommentProfessional

View all (6) »

Activities
  1. ALK treatment and resistance in NSCLC

    Anthonie Wekken, van der (Speaker)
    5-Feb-2020

    Activity: Talk or presentationAcademic

  2. ALK treatment and resistance in NSCLC

    Anthonie Wekken, van der (Speaker)
    4-Feb-2020

    Activity: Talk or presentationAcademic

  3. Treatment of mutations with TKI

    Anthonie Wekken, van der (Speaker)
    2-May-2019

    Activity: Talk or presentationProfessional

View all (12) »

ID: 35892471